A Phase II Study of Capecitabine and Docetaxel in Previously Untreated Advanced Non-Small Cell Lung Cancer Patients

Clinical trial NCT00201825 · COMPLETED

Trial details

NCT number: NCT00201825
Sponsor: Tony Bekaii-Saab
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Non-Small-Cell Lung Carcinoma

Start date: 2004-12-01
Primary completion: 2012-12-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.